Photon counting CT for liver metastasis from colorectal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a new type of CT scanner (photon counting CT) to see if it can better find liver spread from colorectal cancer. If you have colorectal cancer and need a liver check, this might help improve detection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have colorectal cancer (no biopsy needed yet)
- You will have a special CT scan (photon counting CT) as part of your care
- You will also have an MRI with a special contrast dye for the liver
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how well MRI can evaluate liver metastases (spread to the liver) from colorectal cancer. If you have measurable liver lesions, your MRI results may help doctors better track and plan care.
This trial tests a new PET/CT scan using a special tracer to detect cancer that has spread to the lining of the abdomen (peritoneal carcinomatosis) in people with colorectal, stomach, ovarian, or pancreatic cancer. It aims to see if this scan is better at finding the spread than standard imaging.
This study tests a new, more detailed type of CT scan (called photon-counting CT) to see if it can better show how far rectal cancer has grown or spread. If you are already getting standard scans to stage your cancer, this study adds an extra CT scan with contrast dye to get clearer pictures.
This trial uses a special PET scan called 18F-FDG to see how well your first chemotherapy is working, just a couple of weeks after you start. The goal is to find out early whether the treatment is helping, so you and your doctor can decide together if you should continue or switch to a different approach.
This study tests whether a new type of MRI scan can better detect and measure liver disease, including fatty liver and scarring, compared to standard CT scans. If you have chronic liver disease, this study may help improve how we diagnose and track it.
This trial studies how a whole-body PET/CT scan using a “tracer” called 18F-FDG can help decide which people with liver cancer (HCC) may benefit from a liver transplant. It may help the transplant team better sort out who is likely to do well after transplant.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.